BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9973648)

  • 1. Immunocytochemical staining of normal and leukemic myeloid cells with the antibody EBM11 (CD68).
    Shome DK; Raju GM; Gupta NK
    Acta Haematol; 1998; 100(4):216-8. PubMed ID: 9973648
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of C-kit receptor in the diagnosis of leukemia: a relationship between expression of C-kit receptor and that of CD33 in leukemic blasts.
    Muroi K; Amemiya Y; Miura Y; Nakamura M; Suda T
    Leuk Res; 1993 Aug; 17(8):725-6. PubMed ID: 7689130
    [No Abstract]   [Full Text] [Related]  

  • 3. Useful panel of antibodies for the classification of acute leukemia by immunohistochemical methods in bone marrow trephine biopsy specimens.
    Chuang SS; Li CY
    Am J Clin Pathol; 1997 Apr; 107(4):410-8. PubMed ID: 9124209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harlequin cell: Ubiquitous or pathognomic?
    Jain G; Kumar C; Chopra A
    Int J Lab Hematol; 2020 Apr; 42(2):e42-e44. PubMed ID: 31424608
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulation of myeloid cell proliferation and survival by p75/AIRM1 and CD33 surface receptors.
    Mingari MC; Vitale C; Romagnani C; Falco M; Moretta L
    Adv Exp Med Biol; 2001; 495():55-61. PubMed ID: 11774609
    [No Abstract]   [Full Text] [Related]  

  • 6. [Monoclonal antibody therapies for acute leukemia].
    Takeshita A; Ono R
    Rinsho Ketsueki; 2002 May; 43(5):353-6. PubMed ID: 12096485
    [No Abstract]   [Full Text] [Related]  

  • 7. Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia.
    Caron PC; Dumont L; Scheinberg DA
    Clin Cancer Res; 1998 Jun; 4(6):1421-8. PubMed ID: 9626458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD33 detection by immunohistochemistry in paraffin-embedded tissues: a new antibody shows excellent specificity and sensitivity for cells of myelomonocytic lineage.
    Hoyer JD; Grogg KL; Hanson CA; Gamez JD; Dogan A
    Am J Clin Pathol; 2008 Feb; 129(2):316-23. PubMed ID: 18208813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of monoclonal antibodies against primary myeloid granules in normal and leukemic cells.
    Elghetany MT; Sullivan AK; Kurec AS; MacCallum JM; Bloomfield CD; Sobol RE; Davey FR
    Am J Clin Pathol; 1992 Oct; 98(4):430-6. PubMed ID: 1415023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monoclonal antibody therapy targeting surface antigens of leukemic cells].
    Meng FY; Fu YB
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):441-3. PubMed ID: 15854546
    [No Abstract]   [Full Text] [Related]  

  • 11. Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry.
    Kunisch E; Fuhrmann R; Roth A; Winter R; Lungershausen W; Kinne RW
    Ann Rheum Dis; 2004 Jul; 63(7):774-84. PubMed ID: 15194571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of monoclonal anti-myeloperoxidase (MPO7) for diagnosing acute leukaemia.
    Storr J; Dolan G; Coustan-Smith E; Barnett D; Reilly JT
    J Clin Pathol; 1990 Oct; 43(10):847-9. PubMed ID: 1977771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversing clonality in leukemia.
    Turhan AG; Eaves CJ; Humphries RK; Phillips GL; Eaves AC
    Semin Hematol; 1991 Jul; 28(3 Suppl 4):5-8. PubMed ID: 1780753
    [No Abstract]   [Full Text] [Related]  

  • 14. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the bcr/abl gene in bone marrow macrophages in CML and alterations during interferon therapy--a fluorescence in situ hybridization study on trephine biopsies.
    Thiele J; Schmitz B; Fuchs R; Kvasnicka HM; Lorenzen J; Fischer R
    J Pathol; 1998 Nov; 186(3):331-5. PubMed ID: 10211125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of alemtuzumab in patients with CD52-positive acute leukemia.
    Tibes R; Keating MJ; Ferrajoli A; Wierda W; Ravandi F; Garcia-Manero G; O'Brien S; Cortes J; Verstovsek S; Browning ML; Faderl S
    Cancer; 2006 Jun; 106(12):2645-51. PubMed ID: 16688777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Native antibody and antibody-targeted chemotherapy for acute myeloid leukemia.
    Sievers EL
    Adv Pharmacol; 2004; 51():169-83. PubMed ID: 15464909
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth kinetics and blast-colony forming cell binding capacity of stromal cells in various haematological malignancies.
    el-Khatib Y; Gidáli J; Fehér I; Mód A; Poros A; Hollán S
    Haematologia (Budap); 1991; 24(2):77-82. PubMed ID: 1816058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel monoclonal antibody, KOR-SA3544 which reacts to Philadelphia chromosome-positive acute lymphoblastic leukemia cells with high sensitivity.
    Mori T; Sugita K; Suzuki T; Okazaki T; Manabe A; Hosoya R; Mizutani S; Kinoshita A; Nakazawa S
    Leukemia; 1995 Jul; 9(7):1233-9. PubMed ID: 7543176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody.
    Soligo D; Delia D; Oriani A; Cattoretti G; Orazi A; Bertolli V; Quirici N; Deliliers GL
    Leukemia; 1991 Dec; 5(12):1026-30. PubMed ID: 1723130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.